Chair(s): Nazia Chaudhuri, Wim A. Wuyts, Michael Kreuter
Session type: State of the art session
Rachel Chambers
Session content
From bench to bedside: how advancements in scientific knowledge lead to new therapies for pulmonary fibrosis
Rachel Chambers
Replay
Slides
Sabina A. Guler
Replay
Slides
Argyris Tzouvelekis
Replay
Slides
Sheetu Singh
Replay
Slides
Replay
Session aims
to describe the bench-to-bedside approach in the development of therapies for interstitial lung diseases; to highlight the emerging therapeutic interventions for the management of interstitial lung diseases; to describe non-pharmacological approaches for the management of interstitial lung diseases; to explore the lessons learnt from other organ systems with respect to the pathophysiology of pulmonary fibrosis.